Encore Medical Education announces publication of the Official... - 01 December 2022 18:45

SAN ANTONIO, Dec. 1, 2022 /PRNewswire-AsiaNet/ -- - Best of SABCS(R) News Highlights coverage will provide daily expert video summaries along with original presentation slides of the most significant breast cancer trials for oncologists worldwide. Encore Medical Education [http://www.encor...

  New CRISPR/Cas9 license agreement for ERS Genomics and Cosmo Bio - 01 December 2022 11:00

DUBLIN, Dec. 1, 2022 /PRNewswire-AsiaNet/ -- ERS Genomics Limited ('ERS') is pleased to announce a new license agreement with Cosmo Bio. This is a non-exclusive license agreement granting Japan's Cosmo Bio access to the ERS CRISPR/Cas9 patent portfolio. ERS, co-founded by Dr. Emmanuelle C...

  LUCIDITY phase 3 topline data presented at CTAD for HMTM – the... - 01 December 2022 09:13

ABERDEEN, Scotland and SINGAPORE, Nov. 30, 2022 /PRNewswire-AsiaNet/ -- - Tau aggregation inhibitor, HMTM, is an oral drug with a strong safety profile, having no risk of amyloid related imaging abnormalities - Topline results for the Phase 3 study, LUCIDITY, were shared at the Clinical Trials in Alzheimer's Diseas...

  Menarini Group Presents Updated Results from Pivotal Phase 3 E... - 01 December 2022 03:52

FLORENCE, Italy, November, 30, 2022, /PRNewswire-AsiaNet/-- • Elacestrant demonstrated longer progression-free survival (PFS) vs SOC endocrine therapy with medians up to 8.6 months, positively associated with the duration of prior treatment with CDK4/6 inhibitors • Elacestrant side effects were manageable...

  Global alliance of heart patient organizations unveils new Glo... - 30 November 2022 19:00

GALWAY, Ireland, Nov. 30, 2022 /PRNewswire-AsiaNet/-- The Global Heart Hub has today launched its Global Cholesterol Action Plan[https://invisiblenation.globalhearthub.org/] to reduce the impact of unhealthy cholesterol levels . Presented at their annual UNITE Summit , the Action Plan follows and bui...

  TargEDys and SymbioPharm enter an exclusive partnership to lau... - 29 November 2022 21:15

PARIS, Nov. 29, 2022 /PRNewswire-AsiaNet/ -- TargEDys and SymbioPharm signed an exclusive marketing and distribution agreement for the launch of SymbioLife(R) Satylia(R) in Germany. The novel dietary supplement based on the next-generation probiotic Hafnia alvei HA4597 will be available from...

  Probiotic strain SNZ 1969(R) helps manage IBS-D & IBS-C sympto... - 29 November 2022 19:06

HYDERABAD, India, Nov. 29, 2022 /PRNewswire-Asianet/ -- Latest study shows Sanzyme Biologics's Bacillus coagulans SNZ 1969(R)(Weizmannia coagulans SNZ 1969), a natural spore forming probiotic strain over five decades of use and more than 30 human studies across age groups found to be effective in m...

  COLOTECT - Non-invasive Colorectal Cancer Screening Test has b... - 25 November 2022 21:58

BANGKOK, Thailand, Nov. 25, 2022 /Xinhua-AsiaNet/-- COLOTECT is a non-invasive colorectal cancer (CRC) self-sampling test that can detect the methylation status of exfoliated cell genes in the intestine, help screen for colorectal cancer and precancerous lesions risk, and detect bowel cancer risk e...

  CHUV, CERN and THERYQ join forces for a world first in cancer ... - 25 November 2022 20:15

LAUSANNE, Switzerland, and PEYNIER, France, Nov. 25, 2022, /PRNewswire-AsiaNet/ -- The Centre Hospitalier Universitaire Vaudois (CHUV) in Lausanne, Switzerland, the European Laboratory for Particle Physics (CERN) and THERYQ (ALCEN Group) have signed an agreement for the world-first development of a revolutionary FLASH radiothera...

  The 13th China (Taizhou) International Medical Expo successful... - 23 November 2022 22:07

TAIZHOU, China, Nov. 23, 2022 /Xinhua-AsiaNet/-- From November 19 to 21, the 13th China (Taizhou) International Medical Expo was held in China Medical City (CMS). Themed "Healthy China Strategy Leading the Construction of Demonstration Zones", this year's expo held 23 special events including th...